National Institute on Drug Abuse (NIDA)
Scientific Director: Amy Newman, Ph.D.
The NIDA Intramural Research Program (IRP) is dedicated to conducting state-of-the-art research on basic mechanisms that underlie drug abuse and addiction and developing new methods of the treatment. The program supports a comprehensive research portfolio that focuses on the biological, social, behavioral, and neuro-scientific bases of drug abuse.
The IRP Research is supported at the molecular, genetic, cellular, animal, and clinical levels and is conceptually integrated, highly innovative, and focused on major problems in the field. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction (and associated diseases), and to translate this knowledge into improved strategies for preventing, treating, and reducing the negative consequences for the individual and for society caused by drug abuse and addiction.
This page was last updated on Tuesday, January 11, 2022